Chinook Therapeutics Inc. .

05/20/2022 | Press release | Distributed by Public on 05/20/2022 14:12

Chinook Therapeutics Presents Updated Data from BION-1301 Phase 1/2 Trial in Patients with IgA Nephropathy (IgAN) and from Atrasentan Preclinical Mechanism of Action Studies at[...]